Example: Heart Attack

Clinical Trials on Glabellar Crease

Total 10000 results

NCT03220893

Completed

Molecular Breast Imaging and Digital Breast Tomosynthesis in Screening Patients With Dense Breast Tissue

Breast Carcinoma
NCT05703399

Active, not recruiting

Long Term Followup of Patients Enrolled in MC1137, BEAUTY Study

Breast Carcinoma
NCT02728076

Active, not recruiting

MRI-Based Preoperative Accelerated Partial Breast Irradiation

Breast Cancer
NCT06361056

Completed

Mobile Health App to Promote Participation of Black Women in Breast Cancer Clinical Trials

Breast Cancer
NCT02513394

Active, not recruiting

PALbociclib CoLlaborative Adjuvant Study (PALLAS)

Breast Cancer
NCT05909397

Active, not recruiting

Vepdegestrant (ARV-471/PF-07850327) + Palbociclib vs Letrozole + Palbociclib in ER(+)/HER2(-) Advanced Breast Cancer (VERITAC-3)

Breast Cancer
NCT05548127

Active, not recruiting

TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study A)

Breast Cancer
NCT03237572

Terminated

Focused Ultrasound and Pembrolizumab in Metastatic Breast Cancer (Breast-48)

Breast Cancer
NCT02520063

Completed

Combination of Letrozole, Everolimus and TRC105 in Postmenopausal Women With Hormone-Receptor Positive and Her2 Negative Breast Cancer

Breast Cancer
NCT01468246

Active, not recruiting

The Young Women's Breast Cancer Study (HOHO)

Breast Cancer
NCT05130840

Active, not recruiting

Monitoring for Cancer Spread to the Central Nervous System (CNS) in People With Breast Cancer

Breast Cancer
NCT01992432

Active, not recruiting

Brain Functional MRI in Older Women With Breast Cancer (Brain fMRI-BC) (Brain fMRI-BC)

Breast Cancer
NCT03289039

Terminated

Neratinib +/- Fulvestrant in HER2+, ER+ Metastatic Breast Cancer

Breast Cancer
NCT04906395

Active, not recruiting

Ovarian Suppression Evaluating Subcutaneous Leuprolide Acetate in Breast Cancer (OVELIA)

Breast Cancer
NCT04320979

Active, not recruiting

Postmastecomy Internal Mammary Nodal Irradiation for High-risk Breast Cancer Patients

Breast Cancer
NCT01413269

Completed

Randomized Study of Hypofractionated and Conventional Fractionation Radiotherapy After Breast Conservative Surgery

Breast Cancer
NCT05645536

Enrolling by invitation

Safety Extension Study for Subjects With HR+, HER2- Breast Cancer for Subjects Who Have Completed the OVELIA Study

Breast Cancer
NCT05787249

Completed

Improving Utilization of Supplemental Breast MRI Screening for Women With Extremely Dense Breasts

Breast Cancer
NCT04225572

Completed

Physical Rehabilitation Evaluation and Optimal Physical Therapy (PRE-OPT)

Breast Cancer
NCT06536556

Terminated

Effects of a Single Chemotherapy Administration on Skeletal Muscle of Breast Cancer Patients: Comparison of Paclitaxel vs Paclitaxel + Trastuzumab vs Paclitaxel + Carboplatine: the PROTECT-06 Bis Study (PROTECT-06-bis)

Breast Cancer
NCT02276885

Active, not recruiting

Prone Partial Breast Irradiation (PBI): a Prospective Randomized Trial

Breast Cancer
NCT04131933

Completed

Evaluating Whether Integration of Prognostic and Predictive Algorithms Into Routine Clinical Practice Effect Whether Oncologists Order Multigene Assays in Patients With Early Stage Breast Cancer (REaCT-Algorith)

Breast Cancer
NCT05226663

Active, not recruiting

A Radiotracer ([18F]FluorThanatrace) by PET/CT for the Imaging of Breast Cancer

Breast Carcinoma
NCT04735367

Completed

Study to Evaluate Overall Survival in Japanese Patients With HR+/HER2- Advanced Breast Cancer Treated With Palbociclib Plus Letrozole

Breast Cancer
NCT02783690

Completed

A Trial of 15 Fraction vs 25 Fraction Pencil Beam Scanning Proton Radiotherapy After Mastectomy in Patients Requiring Regional Nodal Irradiation

Breast Cancer
NCT01516190

Active, not recruiting

The Preoperative Health & Body Study (PreHab)

Breast Cancer
NCT03671330

Completed

Efficacy and Safety of Ribociclib in Pre- and Postmenopausal Chinese Women With HR Positive, HER2-negative, Advanced Breast Cancer.

Breast Cancer
NCT05634954

Withdrawn

Study to Evaluate Safety and Dosimetry of [18F]GEH121224 in Patients With Locally Advanced or Metastatic Breast Cancer

Breast Cancer
NCT03822468

Completed

Study of 2 Ribociclib Doses in Combination With Aromatase Inhibitors in Women With HR+, HER2- Advanced Breast Cancer (AMALEE)

Breast Cancer
NCT04794816

Withdrawn

What Women Want: Real Time Results During Screening Mammography in the Era of Patient-Experience Driven Care

Breast Carcinoma
NCT00210223

Completed

Radiofrequency of Breast Cancers in Non Surgical Patients (RF-SEIN)

Breast Cancer
NCT02867475

Completed

REduction of Physical Inactivity Facing the CAncer (RESCA)

Breast Cancer
NCT03264547

Completed

A Study to Compare Eribulin Mesylate + Pertuzumab + Trastuzumab With Paclitaxel or Docetaxel + Pertuzumab + Trastuzumab

Breast Cancer
NCT05501769

Completed

ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer (TACTIVE-E)

Breast Cancer
NCT03716180

Active, not recruiting

DAPHNe: Paclitaxel/Trastuzumab/Pertuzumab in HER2-Positive BC

Breast Cancer
NCT03778931

Completed

Phase 3 Trial of Elacestrant Versus Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer (EMERALD)

Breast Cancer
NCT06522971

Active, not recruiting

Effects of Physical Exercise on Response to Treatement in Breast Cancer (CancerBeat)

Breast Cancer
NCT03802604

Completed

Combination of Talimogene Laherparepvec With Atezolizumab in Early Breast Cancer (PROMETEO)

Breast Cancer
NCT02007512

Completed

Efficacy and Safety Study of Enzalutamide in Combination With Exemestane in Patients With Advanced Breast Cancer

Breast Cancer
NCT05549505

Completed

A Trial Using ARV-471 or Anastrozole in Post-Menopausal Women With Breast Cancer Prior to Surgery

Breast Cancer
NCT06060561

Suspended

Genetic Testing to Improve Management of Patients Undergoing Breast Biopsy

Breast Carcinoma
NCT05377229

Completed

MarginProbe 2.0 Data Collection Protocol

Breast Cancer
NCT05051631

Completed

BRAVE Strategy - Breast Cancer Risk Assessment -achieVing Equity (BRAVE)

Breast Cancer
NCT03439735

Active, not recruiting

Determinants of Resistance to Endocrine Therapy and a Cyclin-dependent Kinases 4 and 6 (CDK4/6) Inhibitor for HR+ MBC

Breast Cancer
NCT05623488

Terminated

CAR T Cells in Mesothelin-Expressing Breast Cancer

Breast Cancer
NCT06683482

Completed

A Qualitative Study on Advanced Breast Cancer Patients and Their Caregivers in Spain

Breast Cancer
NCT05859971

Completed

ICG and SLN Mapping

Breast Cancer
NCT06344793

Completed

Initial CDK 4/6 Inhibitor Plus Endocrine Therapy Versus Initial Chemotherapy in HR Positive, HER2 Negative Unresectable or Metastatic Breast Cancer

Breast Cancer
NCT05417451

Completed

Multi-Omics Study of the Effect and Mechanisms of Acupuncture on Psychoneurological Symptoms Among Breast Cancer Survivors

Breast Cancer
NCT04656353

Completed

An Impact Assessment of a Culturally Tailored Online Psychosocial Program for Chinese Immigrant Women With Breast Cancer

Breast Cancer

Clinical Trials on Glabellar Crease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations